510(k) K822298

DIAGNOSTIC RADIOIMMUNOASSAY FOR QUANTI by Nuclear Medical Laboratories, Inc. — Product Code JFH

K822298 is an FDA 510(k) premarket notification submitted by Nuclear Medical Laboratories, Inc. for the device "DIAGNOSTIC RADIOIMMUNOASSAY FOR QUANTI". The FDA issued a decision of Substantially Equivalent on September 2, 1982. The device falls under product code JFH (Acid Phosphatase (Prostatic), Tartrate Inhibited), a Class II device regulated under 21 CFR 862.1020. Nuclear Medical Laboratories, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 2, 1982
Date Received
August 3, 1982
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Acid Phosphatase (Prostatic), Tartrate Inhibited
Device Class
Class II
Regulation Number
862.1020
Review Panel
CH
Submission Type